![Kevin Healy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Healy
Conseiller Juridique Général chez
ENTRADA THERAPEUTICS, INC.
Profil
Kevin Healy is Senior Vice President-Regulatory Affairs at Entrada Therapeutics, Inc. since 2024.
Former roles include Head-Regulatory Affairs at Mallinckrodt Pharmaceuticals, Enzyvant Therapeutics, Inc., and Roivant Sciences, Inc. Education includes a doctorate from the University of Wisconsin and an undergraduate degree from Cornell University.
Postes actifs de Kevin Healy
| Sociétés | Poste | Début |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Conseiller Juridique Général | 01/02/2024 |
Anciens postes connus de Kevin Healy
| Sociétés | Poste | Fin |
|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Conseiller Juridique Général | - |
Enzyvant Therapeutics, Inc.
 Enzyvant Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for treatment of rare diseases | Conseiller Juridique Général | - |
Formation de Kevin Healy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
Enzyvant Therapeutics, Inc.
Enzyvant Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for treatment of rare diseases | Health Technology |
